Evidence map›Paper›PMID 39981253›Full record

ArticleFrontiers in immunology2025

Laura Batlle-Masó, Janire Perurena-Prieto, Laura Viñas-Giménez, Aina Aguiló-Cucurull, Paula Fernández-Álvarez, Johana Gil-Serrano, Mar Guilarte, Roger Colobran

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Laura Batlle-MasóInfection and Immunity in Pediatric Patients Group, Vall d'Hebron Research Institute (VHIR), Barcelona, Catalonia, Spain.
Janire Perurena-PrietoTranslational Immunology Group, Vall d'Hebron Research Institute (VHIR), Barcelona, Catalonia, Spain.
Laura Viñas-GiménezTranslational Immunology Group, Vall d'Hebron Research Institute (VHIR), Barcelona, Catalonia, Spain.
Aina Aguiló-CucurullTranslational Immunology Group, Vall d'Hebron Research Institute (VHIR), Barcelona, Catalonia, Spain.
Paula Fernández-ÁlvarezDepartment of Clinical and Molecular Genetics, Vall d'Hebron University Hospital (HUVH), Barcelona, Catalonia, Spain.
Johana Gil-SerranoDepartment of Allergy, Vall d'Hebron University Hospital (HUVH), Barcelona, Catalonia, Spain.
Mar GuilarteDepartment of Allergy, Vall d'Hebron University Hospital (HUVH), Barcelona, Catalonia, Spain.
Roger ColobranTranslational Immunology Group, Vall d'Hebron Research Institute (VHIR), Barcelona, Catalonia, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hereditary angioedema (HAE) is a rare genetic disease, characterized by transient and self-limiting episodes of subcutaneous or submucosal swelling that spontaneously resolve within two to five days. The most common form of HAE, HAE-C1-INH, is caused by deleterious mutations in the

Indexed as

Angioedemas, HereditaryComplement C1 Inhibitor ProteinMosaicismAdultFemaleHumansMaleMutationPedigreeComplement C1 Inhibitor ProteinSERPING1 protein, humanC1 inhibitor deficiencygenetic counselinggonosomal mosaicismhereditary angioedemaSERPING1somatic variant

Identifiers

PMID39981253
PMCPMC11839619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.